IL6 and metabolic dysfunction-associated steatohepatitis: In NASH, chronic HBV, and HCV, common mechanisms driving HCC development include: the persistence of liver inflammation, immune-mediated liver injury, and ultimately up-regulated release of pro-inflammatory factors TNF-α and IL-6.